US7867001049
US7867001049
Sagimet Biosciences Inc. - Seri
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 56.889.000 | 54.454.000 | 4.5% | |
| Operating Income | -56.889.000 | -54.454.000 | 4.5% |
| Pretax Income | -51.038.000 | -45.567.000 | 12.0% |
| Net Income Common Stockholders | -51.038.000 | -45.567.000 | 12.0% |
| -- | -- | -- | |
| -- | -- | -- |